Navigation Links
DermTech and Rady Children's Hospital-San Diego, Initiate Study to Understand Effects of Vitamin D as a Treatment for Atopic Dermatitis in Children and Young Adults
Date:10/27/2008

DermTech's Non-invasive EGIR Technology to be Employed to Generate Genetic,

Objective Data on Therapy Response

LA JOLLA, Calif., Oct 27 /PRNewswire/ -- DermTech, a biotechnology company developing EGIR(TM) (Epidermal Genetic Information Retrieval) technology for the non-invasive early detection of melanoma, drug development and other applications, and Rady Children's Hospital-San Diego, today announced the initiation of a study involving the use of the company's EGIR technology as a vehicle to evaluate oral and/or topical Vitamin D as a treatment for atopic dermatitis (eczema).

"We are looking forward to working with the team at DermTech and employing the company's non-invasive EGIR ("tape stripping") technology as part of our research," said Lawrence F. Eichenfield, MD, Chief of Pediatric and Adolescent Dermatology, Rady Children's Hospital and the Principal Investigator on the study. "Atopic dermatitis is a condition that gets little public attention but can have a major negative impact on a child or young adult's quality of life. A recent small study has suggested that Vitamin D may help bolster the skin's immune responses, but more data is needed. We will be using the EGIR technology to evaluate the expression of defense proteins in the affected population before and after treatment with Vitamin D to help elucidate a potentially important part of atopic dermatitis immunology and therapy."

Atopic dermatitis is a common, chronic inflammatory skin disease with complex immunologic features. It has 15-20% prevalence in children within the first decade of life and there are limited therapeutic options.

In "normal skin", anti-microbial peptides (AMP) such as cathelicidin (hCAP18/LL37) help regulate innate immunity by directly killing microbes including Gram-positive and Gram-negative bacteria, as well as fungi and certain viruses. Patients with atopic dermatitis however, lack sufficient expression of these AMPs and
'/>"/>

SOURCE DermTech
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. DermTech Appoints BioStatistical Pioneer, John Quackenbush, Ph.D., as a Member of the Companys Scientific Advisory Board
2. DermTech Is Issued U.S. Patent for the Early Detection, Staging and Monitoring of Melanoma
3. DermTech Study on Melanoma Molecular Diagnostic to Be Presented at AACR
4. DermTech Names Herbert A. Fritsche, Ph.D., Chief of Clinical Chemistry at M.D. Anderson Cancer Center to Companys Scientific Advisory Board
5. Neurobiological Technologies Announces Amendment of License and Cooperation Agreement with Merz Pharmaceuticals and Childrens Hospital
6. ABR-Affinity BioReagents to Participate in the American Association for Cancer Research Meeting in San Diego, California, April 12 - 16, 2008
7. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
8. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
9. Proceedings to Affirm Merger Between PharmAthene and Healthcare Acquisition Corp Initiated in Delaware Chancery Court
10. Dawson James Securities Initiates Research Coverage on CryoCor, Inc. (Nasdaq: CRYO) with a Strong Buy Rating and $6.00 Target Price
11. YM BioSciences USA cleared by US FDA to initiate Phase II clinical trial of nimotuzumab in children with inoperable, recurrent brain cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... Texas (PRWEB) November 26, 2014 ... Industry is an in-depth research report on the ... the report introduces Palmitic Acid, basic information, including ... policy analysis, and news analysis, etc. , ... analyzes Palmitic Acid market in China ...
(Date:11/24/2014)... Nov. 24, 2014  IGI Laboratories, Inc. (NYSE MKT: ... specialty generic pharmaceutical company, today announced it has submitted ... U.S. Food and Drug Administration (FDA), which brings the ... seven, with eighteen submissions now pending at the FDA. ... CEO of the Company, commented, "Our team here at ...
(Date:11/24/2014)... , Nov. 24, 2014   Veracyte, Inc. ... H. Anderson , president and chief executive officer, will present ... th Annual Healthcare Conference on Tuesday, December 2, 2014 ... . The live audio webcast and subsequent replay ... . Please connect to the website at least 15 minutes ...
(Date:11/24/2014)... , Nov. 24, 2014  Spherix Incorporated ... company committed to the fostering and monetization of ... v. VTech Telecommunications Ltd.,  Case No. 3:13-cv-03494-M and  ... No. 3:13-cv-03496-M, both in the United States District ... Texas . On November ...
Breaking Biology Technology:Palmitic Acid Industry Global 2014 Analysis & 2020 Forecasts on Market data, Statics, Development Now at ReportsnReports.com 2Palmitic Acid Industry Global 2014 Analysis & 2020 Forecasts on Market data, Statics, Development Now at ReportsnReports.com 3IGI Laboratories, Inc. Announces ANDA Submission 2Veracyte to Present at the Piper Jaffray 26th Annual Healthcare Conference 2Markman Hearing Held as Scheduled in VTech and Uniden Cases 2
... Data , , THOUSAND OAKS, Calif., June 22 ... that the U.S. Food and Drug Administration (FDA) has asked ... Health Drugs Advisory Committee (RHDAC) on Aug. 13, 2009. The ... for denosumab, a RANK Ligand inhibitor for which Amgen is ...
... Pharmaceutical Research and Manufacturers of America ... statement regarding today,s AARP-White House press conference on health care ... we believe this agreement will be looked back in time ... our troubled health care system. Our $80 billion pledge ...
... COLUMBUS, Ohio, June 22 Mettler-Toledo International Inc. (NYSE: ... has been appointed to its Board of Directors, effective July ... and Chief Executive Officer of Millipore Corporation (NYSE: ... research and biopharmaceutical manufacturing industry. Prior to joining Millipore ...
Cached Biology Technology:Amgen to Participate in Reproductive Health Drugs Advisory Committee Meeting in August 2Amgen to Participate in Reproductive Health Drugs Advisory Committee Meeting in August 3Amgen to Participate in Reproductive Health Drugs Advisory Committee Meeting in August 4Amgen to Participate in Reproductive Health Drugs Advisory Committee Meeting in August 5Amgen to Participate in Reproductive Health Drugs Advisory Committee Meeting in August 6Amgen to Participate in Reproductive Health Drugs Advisory Committee Meeting in August 7PhRMA Statement on AARP-White House Press Conference 2Martin Madaus Joins Mettler Toledo Board of Directors 2
(Date:11/10/2014)... on U.S. store shelves in early 2010, and people ... small packets can be tossed into a washing machine ... powder. The convenience, though, has come with risks for ... Nationwide Children,s Hospital found that from 2012 through 2013, ... younger than 6 years of age swallowing, inhaling, or ...
(Date:11/6/2014)... paper from a team of Florida State University biologists ... could adapt to and survive environmental swings such as ... latest issue of the journal The Plant Cell ... DNA and proteins) is organized in a cell and ... are turned on and others are turned off. , ...
(Date:11/5/2014)... Santamaria, associate professor of biology in the UTSA ... in the nation selected to receive a two-year ... for Exploratory Research (EAGER). The funding supports President ... researchers to create new technology that will demystify ... complex behaviors in neuroscience are broken into the ...
Breaking Biology News(10 mins):Study finds laundry detergent pods, serious poisoning risk for children 2Maize analysis yields whole new world of genetic science 2UTSA biology professor awarded $300,000 NSF grant for brain research 2UTSA biology professor awarded $300,000 NSF grant for brain research 3
... published an overview of sales of various drugs used ... are shown in kilograms of active ingredient; antibacterials, anaesthetics, ... figures are based on sales from wholesalers to pharmacies ... an increase in sales of antibacterials from 2002-2006, sales ...
... the School of Biological Sciences at Queens University, found the ... University College Cork and BirdWatch Ireland. Its natural range is ... the closest it has been spotted to Ireland is in ... was studying the diet of the Barn Owl in Ireland. ...
... emerged as an important signaling molecule in plants - ... tropical medicinal herb as a model plant, researchers have ... and enzymes in plants. In collaborative work with ... and her doctoral student at the Botany Department, University ...
Cached Biology News:For good or ill Ireland gains another mammal species 2Nitric oxide regulates plants as well as people 2
MHC. Sections include: the isolation and functional properties of antigen-presenting cells analysis of MHC class II endocytosis and peptide turnover analysis of signalling via MHC class II molecu...
Supplemental reagent for annexin V assay....
Large-fragment, single-stranded carrier DNA of the highest quality, perfectly suited for all types of yeast transformation....
Qa-1 (L-12)...
Biology Products: